According to DelveInsight, the total diagnosed prevalent population of Diabetic Peripheral Neuropathy in 7 Major Markets was 25,332,829 in 2017. Diabetic Peripheral Neuropathy Market is anticipated to grow with a CAGR of 12% for the study period of 2017-2030. The key players in Diabetic Peripheral Neuropathy market includes Helixmith, Aptinyx Inc., WinSanTor, Regenacy Pharmaceuticals LLC, Novaremed AG., Grünenthal Group, Glenmark Pharmaceuticals and others. For more details, visit: https://www.delveinsight.com/blog/diabetic-peripheral-neuropathy-market/